Intervention

radiation

ClinicalTrials.gov intervention label

Clinical trials11

Recruiting0

Common conditions19

Lead sponsors shown8

Clinical trials

11 shown

Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate CancerNCT02064582 · 2014-05-01

Ion Prostate IrradiationNCT01641185 · 2012-05-01

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive NodesNCT00805597 · 2008-06-01

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and ChemotherapyNCT00864331 · 2008-02-01

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and RadiotherapyNCT00447421 · 2007-02-01

Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerNCT00227565 · 2006-02-01

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung CancerNCT00192036 · 2004-08-01

Partial Breast Irradiation With ChemotherapyNCT00278109 · 2004-07-01

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant RadiotherapyNCT03935802 · 2002-09-01

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the PelvisNCT00033605 · 2002-04-01

Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate CancerNCT00023686 · 2001-10-01

Common conditions

Prostate Cancer3 Breast Cancer2 Non Small Cell Lung Cancer2 Breast Cancer Female1 Carcinoma, Small Cell1 Cervical Cancer1 Colorectal Cancer1 Diarrhea1 Endometrial Cancer1 Fallopian Tube Cancer1 Lung Cancer1 Ovarian Cancer1 Prostatic Neoplasms1 Sarcoma1 SCLC1 Small Cell Lung Cancer1 Unspecified Adult Solid Tumor, Protocol Specific1 Vaginal Cancer1 Vulvar Cancer1

Leading sponsors

Alliance for Clinical Trials in Oncology3 Eli Lilly and Company2 Chinese Academy of Medical Sciences1 Heidelberg University1 International Atomic Energy Agency1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1 University of Jena1 University of Texas Southwestern Medical Center1

Trial status mix

COMPLETED9

TERMINATED2

Phase mix

PHASE26

PHASE34

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.